1
High Doses of 4-aminopyridine in Clinically Complete Chronic Spinal Cord Injury Patients.
Condition(s):Spinal Cord Injuries; ChronicLast Updated:February 21, 2021Active, not recruiting
4-Aminopyridine as an Intervention: 70 Clinical Trials, Page 1 of 7
Hide Studies Not Open or Pending
2
Efficacy and Safety of 4-aminopyridine on Cognitive Performance and Motor Function of Patients With Multiple Sclerosis
Condition(s):Multiple SclerosisLast Updated:September 12, 2019Completed
3
4-aminopyridine Treatment for Nerve Injury
Condition(s):Nerve Injury; Prostate CancerLast Updated:May 16, 2022Recruiting
4
Use of Dalfampridine in Primary Lateral Sclerosis
Condition(s):Motor Neuron Disease, UpperLast Updated:October 3, 2022Active, not recruiting
5
Ampyra for Optic Neuritis in Multiple Sclerosis
Condition(s):Multiple Sclerosis; Optic NeuritisLast Updated:January 30, 2020Completed
6
4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy
Condition(s):Prostate DiseaseLast Updated:November 2, 2018Withdrawn
7
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
Condition(s):Post-ischemic StrokeLast Updated:January 22, 2019Terminated
8
An Open Label, Proof of Concept Study to Evaluate the Effects of Dalfampridine Withdrawal on Gait and Balance Parameters in Subjects With Multiple Sclerosis (MS)
Condition(s):Multiple SclerosisLast Updated:October 14, 2013Completed
9
Short and Long Term Treatment With 4-AP in Ambulatory SMA Patients
Condition(s):Spinal Muscular AtrophyLast Updated:May 18, 2016Completed
10
Fampridine-SR and Optic Neuritis Recovery
Condition(s):Optic NeuritisLast Updated:August 25, 2022Recruiting